This company has been acquired
Salud financiera de hoja de balance de F-star Therapeutics
Salud financiera controles de criterios 3/6
Información clave
17.3%
Ratio deuda-patrimonio
US$9.84m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$35.57m |
| Patrimonio | US$56.94m |
| Total pasivo | US$26.78m |
| Activos totales | US$83.72m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
F-star Therapeutics: Running Into A National Security Roadblock
Sep 22F-star Therapeutics falls on extended CFIUS review for Sino-Biopharma sale
Sep 15F-star Therapeutics: A Merger Arbitrage Opportunity Expected To Close Soon
Jul 29F-star enters license deal with Takeda for a cancer immune therapy antibody
Jul 20Need To Know: Analysts Are Much More Bullish On F-star Therapeutics, Inc. (NASDAQ:FSTX) Revenues
May 18
US$26.50: That's What Analysts Think F-star Therapeutics, Inc. (NASDAQ:FSTX) Is Worth After Its Latest Results
Mar 17These Analysts Just Made An Incredible Downgrade To Their F-star Therapeutics, Inc. (NASDAQ:FSTX) EPS Forecasts
Mar 16F-star Therapeutics: Best-In-Class Tetravalent Bispecific Antibody Technology In Cancers
Jan 27F-star Therapeutics under pressure on pricing $65M stock offering
May 07Here's What F-star Therapeutics, Inc.'s (NASDAQ:FSTX) Shareholder Ownership Structure Looks Like
Mar 17Merck KGaA discloses 5.4% stake in F-star Therapeutics
Feb 02Dosing underway in early-stage study of F-star's FS120 in cancer
Dec 03Análisis de la situación financiera
Pasivos a corto plazo: FSTX's short term assets ($49.6M) exceed its short term liabilities ($14.7M).
Pasivo a largo plazo: FSTX's short term assets ($49.6M) exceed its long term liabilities ($12.1M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: FSTX has more cash than its total debt.
Reducción de la deuda: Insufficient data to determine if FSTX's debt to equity ratio has reduced over the past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: FSTX has less than a year of cash runway based on its current free cash flow.
Pronóstico de cash runway: FSTX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 38.7% each year